L-type calcium channel blocker use and proteinuria among children with chronic kidney diseases

[21] Samuels J(2003)Effects of manidipine and nifedipine on blood pressure and renal function in patients with chronic renal failure: A multicenter randomized controlled trial Ren Fail 25 681-124

[22] Saland J(2004)Differential effects of calcium antagonist subclasses on markers of nephropathy progression Kidney Int 65 1991-273

[23] White CT(2004)Effect of angiotensin-converting enzyme inhibitor/calcium antagonist combination therapy on renal function in hypertensive patients with chronic kidney disease: Chikushi Anti-Hypertension Trial- Benidipine and Perindopril J Clin Med Res 10 117-855

[24] Furth S(2011)Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria Hypertens Res 34 268-28

[25] Warady BA(2015)Effect of N- and T-type calcium channel blocker on proteinuria, blood pressure, and kidney function in hypertensive patients: a meta-analysis Hypertens Res 38 847-1860

[26] Mitsnefes M(2013)Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and Bayesian network meta-analysis BMJ 347 f6008-359

[27] Wühl E(2017)Dihydropyridine calcium channel blockers and renal disease Hypertens Res 40 21-635

[28] Trivelli A(1999)Class differences in the effects of calcium channel blockers in the rat remnant kidney model Kidney Int 55 1849-undefined

[29] Picca S(2004)A randomized, placebo- controlled trial of amlodipine in children with hypertension J Pediatr 145 353-undefined

[30] Litwin M(2005)Efficacy and safety of prolonged amlodipine treatment in hypertensive children Pediatr Nephrol 20 631-undefined

[21] Samuels J(2003)Effects of manidipine and nifedipine on blood pressure and renal function in patients with chronic renal failure: A multicenter randomized controlled trial Ren Fail 25 681-124

[22] Saland J(2004)Differential effects of calcium antagonist subclasses on markers of nephropathy progression Kidney Int 65 1991-273

[23] White CT(2004)Effect of angiotensin-converting enzyme inhibitor/calcium antagonist combination therapy on renal function in hypertensive patients with chronic kidney disease: Chikushi Anti-Hypertension Trial- Benidipine and Perindopril J Clin Med Res 10 117-855

[24] Furth S(2011)Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria Hypertens Res 34 268-28

[25] Warady BA(2015)Effect of N- and T-type calcium channel blocker on proteinuria, blood pressure, and kidney function in hypertensive patients: a meta-analysis Hypertens Res 38 847-1860

[26] Mitsnefes M(2013)Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and Bayesian network meta-analysis BMJ 347 f6008-359

[27] Wühl E(2017)Dihydropyridine calcium channel blockers and renal disease Hypertens Res 40 21-635

[28] Trivelli A(1999)Class differences in the effects of calcium channel blockers in the rat remnant kidney model Kidney Int 55 1849-undefined

[29] Picca S(2004)A randomized, placebo- controlled trial of amlodipine in children with hypertension J Pediatr 145 353-undefined

[30] Litwin M(2005)Efficacy and safety of prolonged amlodipine treatment in hypertensive children Pediatr Nephrol 20 631-undefined